Year: 2023

Video Analytics Market Size to Surpass USD 37.55 billion by 2030, exhibiting a CAGR of 23.9%

Written by Customer Service on October 25, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global Video Analytics Market Size is projected to reach USD 37.55 billion by 2030, at a CAGR of 23.9% during the forecast period.Video Analytics MarketForecast, 2023-2030Pune,India, Oct. 25, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Video Analytics Market Size was valued at USD 6.86 billion in 2022 and is projected to grow from USD 8.27 billion in 2023 to USD 37.55 billion by 2030, exhibiting a CAGR of 23.9% during the forecast period. Video analytics reads video signals with the help of an algorithm to enhance the security of areas that are prone to frequent attacks. This software is witnessing a robust rise in its deployment due to its ability to detect real-time actions and behaviors, offering customers useful insights and alerts. Additionally,...

Diabetes Drugs Market Size to Surpass USD 134.08 Billion by 2030, exhibiting a CAGR of 7.8%

Written by Customer Service on October 25, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the diabetes drugs market size is projected to reach USD 134.08 Billion by 2030, at a CAGR of 7.8% during the forecast periodDiabetes Drugs MarketDiabetes Drugs Market (2023-2030)Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) — The global diabetes drugs market size was valued at USD 66.15 billion in 2022, and it is expected to expand from USD 79.25 billion in 2023 to USD 134.08 billion by 2030, exhibiting a CAGR of 7.8% over the study period. Diabetes mellitus type 1 and type 2 can be treated with the help of diabetes drugs by reducing the body’s blood glucose levels. The market expansion can be credited to the rising incidence of diabetes, specifically type 2 diabetes, coupled with the growing demand for effective drug solutions for the treatment of the disease. Fortune...

Edge Computing Market Size to Surpass USD 139.58 Billion by 2030, exhibiting a CAGR of 36.3%

Written by Customer Service on October 25, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global Edge Computing Market size is projected to reach USD 139.58 Billion by 2030, at a CAGR of 36.3% during the forecast period.Edge Computing MarketForecast, 2023– 2030Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) — The global edge computing market size was valued at USD 11.99 billion in 2022 and is projected to reach USD 139.58 billion by 2030, exhibiting a CAGR of 36.3% during the forecast period. Fortune Business Insights™ presents this information in a report titled, Global Edge Computing Market Forecast, 2023-2030. The global market is predicted to show substantial growth during the forecast timeframe as the demand for edge devices is increasing at a notable rate. These devices typically include Internet of Things (IoT) machines such as mobile point-of-sale...

Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million

Written by Customer Service on October 25, 2023. Posted in Public Companies.

BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) — Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announces today that its subsidiary LSL Laboratory (“LSL”) has received new orders for natural health products. Unless otherwise specified, all amounts are in Canadian dollars. These new orders reflect the addition of new clients, as well as volume increases from certain existing clients. In addition to benefits from the higher production capacity stemming from the relocation of LSL’s activities to a new facility in La Pocatière, the Company’s solid reputation enabled it to take advantage of favourable market conditions. Based on purchase orders received up to this date, the Company believes that the positive effect on its sales could exceed $2.6 million...

EyePoint Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 1, 2023

Written by Customer Service on October 25, 2023. Posted in Public Companies.

WATERTOWN, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 1, 2023 to report its third quarter 2023 financial results and highlight recent corporate developments. To access the live conference call, please register using the audio conference link: https://register.vevent.com/register/BI3b701846a11841ad855aab9d0b8aff10. A live audio webcast of the event can be accessed via the Investors section of the Company website at www.eyepointpharma.com. A webcast replay will also be available on the corporate website at the conclusion of the call. About EyePoint Pharmaceuticals EyePoint...

Apellis Pharmaceuticals to Host Conference Call on November 1, 2023, to Discuss Third Quarter 2023 Financial Results

Written by Customer Service on October 25, 2023. Posted in Public Companies.

WALTHAM, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its third quarter 2023 financial results on Wednesday, November 1, 2023, at 8:00 a.m. ET. To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 90 days following the event. About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the...

Verrica Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 9, 2023

Written by Customer Service on October 25, 2023. Posted in Earnings Releases And Operating Results.

WEST CHESTER, Pa., Oct. 25, 2023 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, November 9, 2023, to provide a corporate update and discuss the Company’s financial results for the third quarter ended September 30, 2023. Individuals may participate in the live call via telephone by dialing 1-877-407-4018 (domestic) or 1-201-689-8471 (international) and using the conference ID: 13741589. Participants are asked to dial in 10 minutes before the start of the call to register. A live audio webcast of the call be accessed by visiting the investor relations section of the Company’s...

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023

Written by Customer Service on October 25, 2023. Posted in Earnings Releases And Operating Results.

BANNOCKBURN, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Financial Results and HighlightsNet revenue of $1,093.0 million, up 7.1% compared to $1,020.9 million in the third quarter of 2022 Gross profit of $254.3 million, or 23.3% of net revenue, up 16.6% compared to $218.0 million, or 21.4% of net revenue, in the third quarter of 2022 Net income of $56.3 million, or $0.31 basic earnings per share, up 45.0% compared to net income of $38.8 million, or $0.21 basic earnings per share, in the third quarter of 2022 Adjusted EBITDA of $109.8 million, up 28.2% compared to $85.6...

Roper Technologies announces third quarter financial results

Written by Customer Service on October 25, 2023. Posted in Earnings Releases And Operating Results.

Increasing full year guidance SARASOTA, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the third quarter ended September 30, 2023. The results in this press release are presented on a continuing operations basis. Third quarter 2023 highlightsRevenue increased 16% to $1.56 billion; organic revenue increased 6% GAAP DEPS increased 24% to $3.21; adjusted DEPS increased 18% to $4.32 GAAP net earnings were $346 million Adjusted EBITDA increased 18% to $652 million GAAP operating cash flow was $631 million; adjusted operating cash flow increased 72% to $647 million“Our market-leading technology businesses continue to operate at a high level and delivered another great quarter, with 16% revenue growth and strong margin performance. Importantly, our third quarter adjusted...

Wabash Announces Third Quarter 2023 Results

Written by Customer Service on October 25, 2023. Posted in Earnings Releases And Operating Results.

Quarterly revenue of $633 million Operating income of $78 million with operating margin of 12.3% Quarterly diluted earnings per share of $1.16 Total backlog of $1.9B, order activity shifting toward later end of typical seasonality 2023 EPS outlook increased $0.20 to $4.65 midpointLAFAYETTE, Ind., Oct. 25, 2023 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the innovation leader of connected solutions for the transportation, logistics and distribution industries, today reported results for the quarter ended September 30, 2023. The Company’s net sales for the third quarter of 2023 reached $632.8 million, reflecting a 3.4% decrease compared to the same quarter of the previous year. The Company achieved consolidated gross profit of $123 million, equivalent to 19.4% of sales. Operating income amounted to $77.6 million, representing...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals